Target intelligence / Profile preview

Scavenger receptor class A member 1 (MSR1) (SR-A1)

Target
SR-A1
Molecular classification
Scavenger receptor, Pattern recognition receptor, Type II transmembrane protein, Membrane-bound receptor
01

Overview

Scavenger receptor class A member 1 (SR-A1), also known as MSR1 or CD204, is a homotrimeric type II transmembrane glycoprotein primarily expressed on the surface of macrophages and dendritic cells (UniProt P21757). It serves as a major pattern recognition receptor (PRR) that identifies and internalizes a diverse range of polyanionic ligands, including oxidized low-density lipoproteins (oxLDL), bacterial surface components, and apoptotic cell debris (PubMed: 25631234). In the context of cardiovascular disease, SR-A1 is a central mediator of atherosclerosis, as its unregulated uptake of oxLDL leads to the formation of lipid-laden foam cells within the arterial wall (PubMed: 12490658). Beyond lipid metabolism, SR-A1 plays a complex role in the immune system by facilitating pathogen clearance and modulating inflammatory cytokine production. In oncology, high expression of SR-A1 is a hallmark of M2-polarized tumor-associated macrophages (TAMs), which promote an immunosuppressive microenvironment and support tumor growth and metastasis (PubMed: 28652333). While no FDA-approved drugs currently target SR-A1, it is being actively investigated as a target for nanoparticle-based drug delivery and as a potential checkpoint for reprogramming the immune response in chronic inflammatory diseases and cancer.

Other names
Macrophage scavenger receptor 1CD204SCARA1SR-AMacrophage scavenger receptor types I and IIMSR
02

Mechanism of action

Binding and internalization of polyanionic ligands through receptor-mediated endocytosis, leading to the clearance of modified lipids, pathogens, or cellular debris, and the subsequent modulation of intracellular signaling pathways such as TLR4 and NF-kappaB.

03

Biological functions

Endocytosis of modified lipoproteinsInnate immune responsePathogen clearanceApoptotic cell clearanceCell adhesionInflammatory signaling modulation
04

Disease associations

AtherosclerosisAlzheimer's diseaseCancerSepsisInflammationDiabetic nephropathy
05

Safety considerations

Increased susceptibility to bacterial and viral infectionsImpaired clearance of apoptotic cells leading to autoimmunityPotential for systemic inflammatory dysregulationOff-target effects due to broad ligand promiscuity
06

Interacting drugs

Fucoidan

4 more in the full profile.

07

Biomarkers

CD204 expression on tumor-associated macrophagesSoluble CD204 (sCD204) serum levelsMSR1 gene polymorphisms

Beyond the preview

Go deeper on Scavenger receptor class A member 1 (MSR1) (SR-A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scavenger receptor class A member 1 (MSR1) (SR-A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call